Kristoffer Ostridge
Overview
Explore the profile of Kristoffer Ostridge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rotevatn A, Eagan T, Tangedal S, Husebo G, Ostridge K, Nielsen R
Eur Clin Respir J
. 2025 Feb;
12(1):2470499.
PMID: 40017817
Background And Aim: The association of the gut microbiota to chronic obstructive pulmonary disease (COPD) phenotypes is underexplored. We aimed to compare stool samples from patients with COPD and subjects...
2.
Gopalakrishnan V, Sparklin B, Kim J, Bouquet J, Kehl M, Kenny T, et al.
Respir Res
. 2025 Jan;
26(1):45.
PMID: 39885466
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterized by airway obstruction and inflammation. Non-typeable Haemophilus influenzae (NTHi) lung infections are common in COPD, promoting frequent exacerbations and...
3.
Thillai M, Oldham J, Ruggiero A, Kanavati F, McLellan T, Saini G, et al.
Am J Respir Crit Care Med
. 2024 Mar;
210(4):465-472.
PMID: 38452227
Despite evidence demonstrating a prognostic role for computed tomography (CT) scans in idiopathic pulmonary fibrosis (IPF), image-based biomarkers are not routinely used in clinical practice or trials. To develop automated...
4.
Devaraj A, Ottink F, Rennison-Jones C, Ble F, Joly O, Azim A, et al.
Am J Respir Crit Care Med
. 2024 Feb;
209(9):1168-1169.
PMID: 38363798
No abstract available.
5.
Ritchie A, Donaldson G, Hoffman E, Allinson J, Bloom C, Bolton C, et al.
Am J Respir Crit Care Med
. 2024 Jan;
209(10):1208-1218.
PMID: 38175920
Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. We hypothesized that structural change would be detected early in the natural history...
6.
Hristova V, Watson A, Chaerkady R, Glover M, Ackland J, Angerman B, et al.
ERJ Open Res
. 2023 May;
9(3).
PMID: 37228288
Rationale: Pulmonary surfactant is vital for lung homeostasis as it reduces surface tension to prevent alveolar collapse and provides essential immune-regulatory and antipathogenic functions. Previous studies demonstrated dysregulation of some...
7.
Waeijen-Smit K, DiGiandomenico A, Bonnell J, Ostridge K, Gehrmann U, Sellman B, et al.
BMJ Open
. 2023 Mar;
13(3):e068787.
PMID: 36868599
Introduction: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) play a pivotal role in the burden and progressive course of chronic obstructive pulmonary disease (COPD). As such, disease management is...
8.
Svendsen C, Kuiper K, Ostridge K, Larsen T, Nielsen R, Hodneland V, et al.
PLoS One
. 2022 Apr;
17(4):e0265682.
PMID: 35476713
Background: COPD and coronary heart disease (CHD) frequently co-occur, yet which COPD phenotypes are most prone to CHD is poorly understood. The aim of this study was to see whether...
9.
Day K, Ostridge K, Conway J, Cellura D, Watson A, Spalluto C, et al.
Chest
. 2020 Nov;
159(4):1391-1399.
PMID: 33245876
Background: Small airways disease (SAD) is a key component of COPD and is a main contributing factor to lung function decline. Research Question: Is SAD a key feature of frequent...
10.
Watson A, Spalluto C, McCrae C, Cellura D, Burke H, Cunoosamy D, et al.
Am J Respir Crit Care Med
. 2019 Aug;
201(1):83-94.
PMID: 31461630
Viral infections are major drivers of exacerbations and clinical burden in patients with asthma and chronic obstructive pulmonary disease (COPD). IFN-β is a key component of the innate immune response...